On Invalid Date, Nrx Pharmaceuticals (NASDAQ: NRXP) reported Q4 2023 earnings per share (EPS) of -$0.50, up 66.67% year over year. Total Nrx Pharmaceuticals earnings for the quarter were -$4.34 million. In the same quarter last year, Nrx Pharmaceuticals's earnings per share (EPS) was -$1.50.
As of Q2 2024, Nrx Pharmaceuticals's earnings has grown year over year. Nrx Pharmaceuticals's earnings in the past year totalled -$30.16 million.
What is NRXP's earnings date?
Nrx Pharmaceuticals's earnings date is Invalid Date. Add NRXP to your watchlist to be reminded of NRXP's next earnings announcement.
What was NRXP's revenue last quarter?
On Invalid Date, Nrx Pharmaceuticals (NASDAQ: NRXP) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Nrx Pharmaceuticals's revenue was $0.00.
What was NRXP's revenue growth in the past year?
As of Q2 2024, Nrx Pharmaceuticals's revenue has grown null year over year. Nrx Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.